Gilead Sciences (GILD) Return on Capital Employed (2009 - 2026)

Gilead Sciences (GILD) has reported Return on Capital Employed for 18 consecutive years, with 21.53% the latest figure, recorded in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 21.53%, up 341.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.53% (up 341.0% YoY), and the FY2025 annual result was 21.23%, up 1781.0% from the prior year.
• Return on Capital Employed was 21.53% for Q1 2026 at Gilead Sciences, up from 21.34% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 23.4% in Q3 2025 and troughed at 1.94% in Q3 2024.
• Average Return on Capital Employed over 5 years is 13.79%, with a median of 14.92% recorded in 2023.
• Year-over-year, Return on Capital Employed tumbled 1444 bps in 2024 and surged 2146 bps in 2025.
• Over 5 years, Return on Capital Employed stood at 14.2% in 2022, then advanced by 5 bps to 14.92% in 2023, then tumbled by 75 bps to 3.71% in 2024, then soared by 475 bps to 21.34% in 2025, then increased by 1 bps to 21.53% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 21.53% in Q1 2026, 21.34% in Q4 2025, and 23.4% in Q3 2025.